Sort
53,477 grants matching “addiction”
HD2A RASC-Administrative Core
$979,111Mark P. McGovern · Stanford University · U2C · FY2025 · DA
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam
$978,594Don C Des Jarlais · New York University · R01 · FY2019 · DA
Genetically encoded indicators for large-scale sensing of neuromodulatory signaling in behaving animals
$978,456Lin Tian · University Of California At Davis · U01 · FY2017 · NS
'Differential Effects of Methamphetamine and Cocaine
$978,408University Of Utah · P01 · FY2003 · DA
Efficacy of a Virtual Reality Neuroscience-based Therapy for Chronic Low Back Pain
$977,764Amanda Way · Cognifisense, Inc. · R44 · FY2024 · NR
Optogenetics and Transgenic Technology Core
$977,493Brandon Harvey · National Institute On Drug Abuse · ZIC · FY2011 · DA
Development of a Commercial Platform for Discovery and Validation of Key Microbial Metabolites in CNS Disorders
$977,355Shoko Iwai · Second Genome, Inc. · R44 · FY2019 · DA
Glutide for Ending Methamphetamine
$977,129Phillip O Coffin · Public Health Foundation Enterprises · UG3 · FY2025 · DA
Development of KLS-13019 for Neuropathic Pain
$977,054Douglas Eric Brenneman · Kannalife Sciences, Inc. · R42 · FY2021 · NS
NDA-Enabling Phase I Lofexidine Program
$976,880James Alvan Longstreth · Us Worldmeds, Llc · U01 · FY2012 · DA
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$976,865Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2008 · DA
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam
$976,840Don C Des Jarlais · New York University · R01 · FY2018 · DA
Immunopharmacotherapy for Mitigating Opioid Addiction
$976,653Kim D Janda · Scripps Research Institute, The · UH3 · FY2017 · DA
IGF::OT::IGF: INTERNATIONAL RESEARCH AND TRAINING SUPPORT . N01DA-13-1151. PERIOD
$976,636Nei-Hyun Park · Iq Solutions, Inc. · N01 · FY2014 · DA
Career Enhancement Core
$976,352Andrea Hobkirk · Pennsylvania State Univ Hershey Med Ctr · U54 · FY2024 · DA
CTN: Harvard University Northern New England Node
$976,208Roger D. Weiss · Mclean Hospital · U10 · FY2007 · DA
Hallucinogens and 5-HT Receptors: Mechanisms and Effects
$976,175Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2008 · DA
Novel Dopamine D3/D2 Receptor Ligands
$976,135Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2025 · DA
Cerebral Structural And Metabolic Correlates Of Aggressive Or Addictive Behavior
$975,764Daniel W Hommer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Epigenetic susceptibility of behavioral and addictive disorders during pre/pubescence after natural disaster exposures in-utero
$975,753Yoko Nomura · Queens College · R01 · FY2025 · DA
Epigenetic susceptibility of behavioral and addictive disorders during pre/pubescence after natural disaster exposures in-utero
$975,753Yoko Nomura · Queens College · R01 · FY2024 · DA
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders
$975,562John M Littleton · Naprogenix, Inc · R44 · FY2021 · AA
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$975,151Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2007 · DA
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
$975,131Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2023 · CA
Molecular profile of proviral reservoirs in HIV-infected drug users
$975,058Xu Yu · Massachusetts General Hospital · R33 · FY2024 · DA